-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
![vet template for publications](https://volition.com/wp-content/uploads/2024/02/vet-template-for-publications-5.png)
Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs
- Share
- Tweet
- Share on Facebook
- Share
![Screenshot 2024-02-16 155127](https://volition.com/wp-content/uploads/2024/02/Screenshot-2024-02-16-155127.png)
![Screenshot 2024-02-16 155127](https://volition.com/wp-content/uploads/2024/02/Screenshot-2024-02-16-155127.png)
Presentation titled: ‘Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies’
Published in Plos Once 2023
Dr Heather Wilson-Robles et al
- Share
- Tweet
- Share on Facebook
- Share
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields